-
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors. Cancer Gene Ther. 2023 Dec 25.
Conley AP, Roland CL, Bessudo A, Gastman BR, Villaflor VM, Larson C, Reid TR, Caroen S, Oronsky B, Stirn M, Williams J, Burbano E, Coyle A, Barve MA, Wagle N, Abrouk N, Kesari S. PMID: 38146006.
View in:
PubMed Mentions: Fields:
-
Commentary on oncolytic viruses: past, present, and future. J Immunother Cancer. 2023 12 21; 11(12).
Larson C, Oronsky B, Reid TR. PMID: 38135348.
View in:
PubMed Mentions: Fields:
Translation:
HumansCells
-
TGF-β: the apex predator of immune checkpoints. Future Oncol. 2023 09; 19(30):2013-2015.
Oronsky B, Cabrales P, Alizadeh B, Caroen S, Stirn M, Williams J, Reid TR. PMID: 37503560.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Data Management 101 for drug developers: A peek behind the curtain. Clin Transl Sci. 2023 09; 16(9):1497-1509.
Oronsky B, Burbano E, Stirn M, Brechlin J, Abrouk N, Caroen S, Coyle A, Williams J, Cabrales P, Reid TR. PMID: 37382299; PMCID: PMC10499417.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy. Cancers (Basel). 2023 Jun 12; 15(12).
Dong T, Shah JR, Phung AT, Larson C, Sanchez AB, Aisagbonhi O, Blair SL, Oronsky B, Trogler WC, Reid T, Kummel AC. PMID: 37370769; PMCID: PMC10296131.
View in:
PubMed Mentions:
2
-
Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME). Front Immunol. 2023; 14:1104753.
Reid T, Oronsky B, Caroen S, Quinn M, Williams J, Cabrales P, Abrouk N. PMID: 36960054; PMCID: PMC10028591.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCTClinical Trials
-
Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001. Int Med Case Rep J. 2022; 15:735-738.
Hammond TC, Lee RC, Oronsky B, Reid TR, Caroen S, Juarez TM, Gill J, Heng A, Kesari S. PMID: 36545548; PMCID: PMC9762260.
View in:
PubMed Mentions:
2
-
ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colorectal Cancer. Clin Colorectal Cancer. 2023 03; 22(1):92-99.
Reid TR, Abrouk N, Caroen S, Oronsky B, Stirn M, Larson C, Beale K, Knox SJ, Fisher G. PMID: 36529613.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansCTClinical Trials
-
Full Remission of CAR-Deficient Tumors by DOTAP-Folate Liposome Encapsulation of Adenovirus. ACS Biomater Sci Eng. 2022 Nov 17.
Huang CH, Dong T, Phung AT, Shah JR, Larson C, Sanchez AB, Blair SL, Oronsky B, Trogler WC, Reid T, Kummel AC. PMID: 36395425.
View in:
PubMed Mentions:
5 Fields:
-
Could nucleocapsid be a next-generation COVID-19 vaccine candidate - author's reply. Int J Infect Dis. 2022 12; 125:227.
Oronsky B, Larson C, Caroen S, Reid TR. PMID: 36347457; PMCID: PMC9636028.
View in:
PubMed Mentions: Fields:
Translation:
HumansCells
-
Development of Adenovirus Containing Liposomes Produced by Extrusion vs. Homogenization: A Comparison for Scale-Up Purposes. Bioengineering (Basel). 2022 Oct 27; 9(11).
Shah JR, Dong T, Phung AT, Reid T, Larson C, Sanchez AB, Oronsky B, Blair SL, Aisagbonhi O, Trogler WC, Kummel AC. PMID: 36354531; PMCID: PMC9687354.
View in:
PubMed Mentions:
1
-
Subset analysis of safety and efficacy in asian patients treated with RRx-001 across three clinical trials. Am J Cancer Res. 2022; 12(9):4448-4457.
Guo X, Wang X, Shen S, Oronsky B, Reid TR, Stirn M, Caroen S, Brinkhaus F, Abrouk NA, Yang L, Wu L, Yu Z. PMID: 36225630; PMCID: PMC9548015.
View in:
PubMed Mentions:
-
RRx-001 and the "Right stuff": Protection and treatment in outer space. Life Sci Space Res (Amst). 2022 Nov; 35:69-75.
Oronsky B, Caroen S, Abrouk N, Reid TR. PMID: 36336372.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Toxicology and biodistribution of AdAPT-001, a replication-competent type 5 adenovirus with a trap for the immunosuppressive cytokine, TGF-beta. Am J Cancer Res. 2021; 11(10):5184-5189.
Larson C, Oronsky B, Abrouk NE, Oronsky A, Reid TR. PMID: 34765319; PMCID: PMC8569352.
View in:
PubMed Mentions:
7
-
A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules. In Vivo. 2021 Jul-Aug; 35(4):1959-1963.
Turner MA, Amirfakhri S, Nishino H, Lwin TM, Savides TJ, Reid TR, Singer BB, Hoffman RM, Bouvet M. PMID: 34182469; PMCID: PMC8286470.
View in:
PubMed Mentions:
3 Fields:
Translation:
HumansAnimals
-
Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical Development. J Med Chem. 2021 06 10; 64(11):7261-7271.
Oronsky B, Guo X, Wang X, Cabrales P, Sher D, Cannizzo L, Wardle B, Abrouk N, Lybeck M, Caroen S, Oronsky A, Reid TR. PMID: 34043360.
View in:
PubMed Mentions:
6 Fields:
Translation:
HumansAnimalsCells
-
A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol. 2021 Feb 20.
Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. PMID: 33609255; PMCID: PMC7896544.
View in:
PubMed Mentions:
130 Fields:
-
A Review of Newly Diagnosed Glioblastoma. Front Oncol. 2020; 10:574012.
Oronsky B, Reid TR, Oronsky A, Sandhu N, Knox SJ. PMID: 33614476; PMCID: PMC7892469.
View in:
PubMed Mentions:
53
-
A short discussion about the SARS-CoV-2 mRNA-1273 vaccine. Int J Infect Dis. 2021 Mar; 104:532-533.
Oronsky B, Gruber HE, Reiners W, Reid TR. PMID: 33493690; PMCID: PMC7825869.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansCells
-
RRx-001, a downregulator of the CD47- SIRPα checkpoint pathway, does not cause anemia or thrombocytopenia. Expert Opin Drug Metab Toxicol. 2021 Apr; 17(4):355-357.
Oronsky B, Cabrales P, Caroen S, Guo X, Scribner C, Oronsky A, Reid TR. PMID: 33432831.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit. Transl Lung Cancer Res. 2021 Jan; 10(1):274-278.
Tomita Y, Oronsky B, Abrouk N, Cabrales P, Reid TR, Lee MJ, Yuno A, Baker J, Lee S, Trepel JB. PMID: 33569311; PMCID: PMC7867783.
View in:
PubMed Mentions:
4
-
Desperate Times, Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19. Semin Oncol. 2020 10; 47(5):305-308.
Oronsky B, Knox S, Cabrales P, Oronsky A, Reid TR. PMID: 32718560; PMCID: PMC7341953.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCellsPHPublic Health
-
TGF-beta: a master immune regulator. Expert Opin Ther Targets. 2020 05; 24(5):427-438.
Larson C, Oronsky B, Carter CA, Oronsky A, Knox SJ, Sher D, Reid TR. PMID: 32228232.
View in:
PubMed Mentions:
62 Fields:
Translation:
HumansAnimalsCells
-
RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic". Oncoimmunology. 2020 04 03; 9(1):1746172.
Oronsky B, Carter CA, Caroen S, Scribner C, Oronsky A, Reid TR. PMID: 33457091; PMCID: PMC7790525.
View in:
PubMed Mentions:
3 Fields:
-
Extended treatment with MY-NEOVAX, personalized neoantigen-enhanced oncolytic viruses, for two end-stage cancer patients. Oxf Med Case Reports. 2019 Nov; 2019(11):461-463.
Bouvet M, Reid TR, Larson C, Oronsky B, Carter C, Morris JC. PMID: 31844525; PMCID: PMC6902621.
View in:
PubMed Mentions:
5
-
REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer. Future Oncol. 2019 Oct; 15(30):3427-3433.
Oronsky B, Reid TR, Larson C, Caroen S, Quinn M, Burbano E, Varner G, Thilagar B, Brown B, Coyle A, Ferry L, Abrouk N, Oronsky A, Scribner CL, Carter CA. PMID: 31509028.
View in:
PubMed Mentions:
18 Fields:
Translation:
HumansCTClinical Trials
-
A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs). Oncoimmunology. 2018; 7(9):e1478648.
Larson C, Oronsky B, Varner G, Caroen S, Burbano E, Insel E, Hedjran F, Carter CA, Reid TR. PMID: 30228948; PMCID: PMC6140583.
View in:
PubMed Mentions:
6 Fields:
-
Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer. J Investig Med High Impact Case Rep. 2018 Jan-Dec; 6:2324709618786319.
Oronsky B, Larson C, Reid TR, Carter CA. PMID: 30083560; PMCID: PMC6069027.
View in:
PubMed Mentions:
6 Fields:
-
Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells. Oncotarget. 2018 May 04; 9(34):23439-23442.
Oronsky B, Reid TR, Oronsky A, Caroen S, Carter CA, Cabrales P. PMID: 29805745; PMCID: PMC5955127.
View in:
PubMed Mentions:
9 Fields:
-
Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Review. Neoplasia. 2018 01; 20(1):92-98.
Oronsky B, Ma P, Reid TR, Cabrales P, Lybeck M, Oronsky A, Oronsky N, Carter CA. PMID: 29227909; PMCID: PMC5726883.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansAnimals
-
What's New in SCLC? A Review. Neoplasia. 2017 Oct; 19(10):842-847.
Oronsky B, Reid TR, Oronsky A, Carter CA. PMID: 28888101; PMCID: PMC5596356.
View in:
PubMed Mentions:
74 Fields:
Translation:
Humans
-
No patient left behind: The promise of immune priming with epigenetic agents. Oncoimmunology. 2017; 6(10):e1315486.
Carter CA, Oronsky BT, Roswarski J, Oronsky AL, Oronsky N, Scicinski J, Lybeck H, Kim MM, Lybeck M, Reid TR. PMID: 29123948; PMCID: PMC5665084.
View in:
PubMed Mentions:
7 Fields:
-
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management. Cancer Chemother Pharmacol. 2017 Nov; 80(5):895-907.
Oronsky B, Caroen S, Oronsky A, Dobalian VE, Oronsky N, Lybeck M, Reid TR, Carter CA. PMID: 28730291; PMCID: PMC5676816.
View in:
PubMed Mentions:
33 Fields:
Translation:
Humans
-
The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury. Expert Rev Hematol. 2017 06; 10(6):575-582.
Cabrales P, Caroen S, Oronsky A, Carter C, Trepel J, Summers T, Reid T, Oronsky N, Lybeck M, Oronsky B. PMID: 28448172; PMCID: PMC8051333.
View in:
PubMed Mentions:
8 Fields:
Translation:
Animals
-
RRx-001 protects against cisplatin-induced toxicities. J Cancer Res Clin Oncol. 2017 Sep; 143(9):1671-1677.
Oronsky B, Reid TR, Larson C, Carter CA, Brzezniak CE, Oronsky A, Cabrales P. PMID: 28417195.
View in:
PubMed Mentions:
12 Fields:
Translation:
Animals
-
RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor. Case Rep Oncol. 2017 Jan-Apr; 10(1):276-280.
Brzezniak C, Oronsky B, Trepel J, Summers TA, Cabrales P, Lee MJ, Day R, Jha S, Caroen S, Zeman K, Ferry L, Harmer C, Oronsky N, Lybeck M, Lybeck HE, Brown JF, Reid TR, Carter CA. PMID: 28512410; PMCID: PMC5422722.
View in:
PubMed Mentions:
-
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials. Expert Opin Investig Drugs. 2017 01; 26(1):109-119.
Oronsky B, Paulmurugan R, Foygel K, Scicinski J, Knox SJ, Peehl D, Zhao H, Ning S, Cabrales P, Summers TA, Reid TR, Fitch WL, Kim MM, Trepel JB, Lee MJ, Kesari S, Abrouk ND, Day RM, Oronsky A, Ray CM, Carter CA. PMID: 27935336.
View in:
PubMed Mentions:
27 Fields:
Translation:
HumansAnimalsCells
-
A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001. Clin Med Insights Oncol. 2016; 10:105-108.
Oronsky B, Caroen S, Zeman K, Quinn M, Brzezniak C, Scicinski J, Cabrales P, Reid TR, Trepel JB, Abrouk ND, Larson C, Oronsky A, Lybeck HE, Day RM, Carter CA. PMID: 27840583; PMCID: PMC5098407.
View in:
PubMed Mentions:
2
-
Conversion of Platinum-Etoposide-Resistant to Sensitive SCLC after Treatment with the Epi-Immunotherapeutic RRx-001: A Case Report. Oncol Res Treat. 2016; 39(11):720-723.
Brzezniak C, Oronsky B, Scicinski J, Caroen S, Cabrales P, Dean Abrouk N, Kim MM, Brown JF, Reid TR, Larson C, Oronsky A, Day R, Degesys A, Carter CA. PMID: 27855386.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents. Biomolecules. 2016 07 04; 6(3).
Oronsky B, Scicinski J, Kim MM, Cabrales P, Salacz ME, Carter CA, Oronsky N, Lybeck H, Lybeck M, Larson C, Reid TR, Oronsky A. PMID: 27384589; PMCID: PMC5039418.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
A look inside the mechanistic black box: Are red blood cells the critical effectors of RRx-001 cytotoxicity? Med Oncol. 2016 Jul; 33(7):63.
Cabrales P, Scicinski J, Reid T, Kuypers F, Larkin S, Fens M, Oronsky A, Oronsky B. PMID: 27229330.
View in:
PubMed Mentions:
6 Fields:
Translation:
AnimalsCells
-
Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets. Case Rep Oncol. 2016 May-Aug; 9(2):285-9.
Carter CA, Oronsky B, Caroen S, Scicinski J, Degesys A, Cabrales P, Reid TR, Brzezniak C. PMID: 27403127; PMCID: PMC4924447.
View in:
PubMed Mentions:
2
-
Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001. Case Rep Oncol. 2016 Jan-Apr; 9(1):164-70.
Carter CA, Schmitz B, Peterson PG, Quinn M, Degesys A, Jenkins J, Oronsky B, Scicinski J, Caroen S, Reid TR, Cabrales P, Brzezniak C. PMID: 27065848; PMCID: PMC4821155.
View in:
PubMed Mentions:
8
-
Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-Distance. Neoplasia. 2015 Sep; 17(9):716-722.
Oronsky B, Carter CA, Reid TR, Scicinski J, Oronsky A, Lybeck M, Caroen S, Stirn M, Oronsky N, Langecker P. PMID: 26476079; PMCID: PMC4611069.
View in:
PubMed Mentions:
9 Fields:
Translation:
HumansAnimals
-
Going viral: a review of replication-selective oncolytic adenoviruses. Oncotarget. 2015 Aug 21; 6(24):19976-89.
Larson C, Oronsky B, Scicinski J, Fanger GR, Stirn M, Oronsky A, Reid TR. PMID: 26280277; PMCID: PMC4652981.
View in:
PubMed Mentions:
74 Fields:
Translation:
HumansAnimalsCells
-
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study. Lancet Oncol. 2015 Sep; 16(9):1133-1142.
Reid T, Oronsky B, Scicinski J, Scribner CL, Knox SJ, Ning S, Peehl DM, Korn R, Stirn M, Carter CA, Oronsky A, Taylor MJ, Fitch WL, Cabrales P, Kim MM, Burris HA, Lao CD, Abrouk NED, Fanger GR, Infante JR. PMID: 26296952.
View in:
PubMed Mentions:
42 Fields:
Translation:
HumansCTClinical Trials
-
Episensitization: Defying Time's Arrow. Front Oncol. 2015; 5:134.
Oronsky BT, Oronsky AL, Lybeck M, Oronsky NC, Scicinski JJ, Carter C, Day RM, Rodriguez Orengo JF, Rodriguez-Torres M, Fanger GF, Reid TR. PMID: 26125013; PMCID: PMC4464068.
View in:
PubMed Mentions:
20
-
Phase I study of everolimus, cetuximab and irinotecan as second-line therapy in metastatic colorectal cancer. Anticancer Res. 2015 Mar; 35(3):1567-73.
Hecht JR, Reid TR, Garrett CR, Beck JT, Davidson SJ, Mackenzie MJ, Brandt U, Rizvi S, Sharma S. PMID: 25750312.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCTClinical Trials
-
Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency. Biomaterials. 2014 Nov; 35(35):9554-61.
Mendez N, Herrera V, Zhang L, Hedjran F, Feuer R, Blair SL, Trogler WC, Reid TR, Kummel AC. PMID: 25154663; PMCID: PMC4157089.
View in:
PubMed Mentions:
24 Fields:
Translation:
HumansAnimalsCells
-
Oncolytic virotherapy. J Vasc Interv Radiol. 2013 Aug; 24(8):1115-22.
Sze DY, Reid TR, Rose SC. PMID: 23885911.
View in:
PubMed Mentions:
38 Fields:
Translation:
HumansAnimalsCells
-
Targeting tumors using nanoparticle platforms: a phase I study of a systemically administered gene therapy system. Mol Ther. 2013 May; 21(5):922-3.
Larson C, Mendez N, Reid T. PMID: 23636291; PMCID: PMC3666643.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study. Cancer. 2013 07 15; 119(14):2555-63.
Infante JR, Reid TR, Cohn AL, Edenfield WJ, Cescon TP, Hamm JT, Malik IA, Rado TA, McGee PJ, Richards DA, Tarazi J, Rosbrook B, Kim S, Cartwright TH. PMID: 23605883.
View in:
PubMed Mentions:
17 Fields:
Translation:
HumansCTClinical Trials
-
Response to intra-arterial oncolytic virotherapy with the herpes virus NV1020 evaluated by [18F]fluorodeoxyglucose positron emission tomography and computed tomography. Hum Gene Ther. 2012 Jan; 23(1):91-7.
Sze DY, Iagaru AH, Gambhir SS, De Haan HA, Reid TR. PMID: 21895536.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansCellsCTClinical Trials
-
Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver. Hum Gene Ther. 2010 Sep; 21(9):1119-28.
Geevarghese SK, Geller DA, de Haan HA, Hörer M, Knoll AE, Mescheder A, Nemunaitis J, Reid TR, Sze DY, Tanabe KK, Tawfik H. PMID: 20486770; PMCID: PMC3733135.
View in:
PubMed Mentions:
79 Fields:
Translation:
HumansCellsCTClinical Trials
-
Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon cancer. Hepatogastroenterology. 2009 May-Jun; 56(91-92):645-9.
Costantini CL, Reid TR, Bouvet M. PMID: 19621672.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Fighting fire with fire: effects of oncolytic virotherapy on underlying viral hepatitis in hepatocellular carcinoma. Mol Ther. 2008 Sep; 16(9):1521-3.
Reid T. PMID: 18725877.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer. Future Oncol. 2008 Aug; 4(4):483-500.
Trivedi M, Budihardjo I, Loureiro K, Reid TR, Ma JD. PMID: 18684060.
View in:
PubMed Mentions:
15 Fields:
Translation:
HumansAnimalsCells
-
Virus combinations and chemotherapy for the treatment of human cancers. Curr Opin Mol Ther. 2008 Aug; 10(4):371-9.
Kumar S, Gao L, Yeagy B, Reid T. PMID: 18683102.
View in:
PubMed Mentions:
45 Fields:
Translation:
HumansAnimalsCells
-
Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib. J Clin Oncol. 2007 Aug 10; 25(23):3544-6.
Saylor PJ, Reid TR. PMID: 17687160.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin. Cancer Gene Ther. 2005 Aug; 12(8):673-81.
Reid TR, Freeman S, Post L, McCormick F, Sze DY. PMID: 15803147.
View in:
PubMed Mentions:
32 Fields:
Translation:
HumansCellsCTClinical Trials
-
Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival. J Vasc Interv Radiol. 2003 Mar; 14(3):279-90.
Sze DY, Freeman SM, Slonim SM, Samuels SL, Andrews JC, Hicks M, Ahrar K, Gupta S, Reid TR. PMID: 12631632.
View in:
PubMed Mentions:
13 Fields:
Translation:
HumansCells
-
A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res. 2003 Feb; 9(2):555-61.
Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM, Kirn DH, Freeman SM. PMID: 12576418.
View in:
PubMed Mentions:
159 Fields:
Translation:
HumansCellsCTClinical Trials
-
Developments in medical oncology and their implications for interventional radiology. Tech Vasc Interv Radiol. 2002 Sep; 5(3):177-81.
Reid TR, Sze DY. PMID: 12524649.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansCells